We all dread Alzheimer’s disease and dementia. The reviewed study is interesting because it relates to something we all want to prevent (Douaud G., et al. 2013).

Researchers demonstrated that B-vitamin treatment reduced by as much as sevenfold the cerebral atrophy in those gray matter regions most vulnerable to the Alzheimer’s disease process.

In the placebo group, higher homocystine levels at the start of the study were associated with faster gray matter atrophy, but this effect was to a large extent prevented by B-vitamin treatment. The beneficial effects of B vitamins were specifically related to participants with high homocysteine levels, 11 µmol per liter.

A good vitamin B-complex formula helps to reduce homocysteine levels. Not everyone can metabolize B vitamins effectively. For that reason, the most effective way to take B-vitamins is in a formula which includes the metabolites of the important B-vitamins. To read more, click here.



Douaud G, Refsum H, de Jager CA, Jacoby R, E Nichols T, Smith SM, Smith AD.Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9523-8. doi: 10.1073/pnas.1301816110. Epub 2013 May 20.


Save Save
  • Category: News
  • Author: Didrik Sopler
  • Published: 2020-03-28
  • Comments: 0
Leave a comment